A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Clinical trials in Lafayette, LA: what is studied
Cancer. The Cancer Center of Acadiana and local urology practices take part in cancer studies, including prostate cancer and bladder cancer; see our oncology clinical trials page.
Digestive diseases. The Gastroenterology Clinic of Acadiana takes part in studies for Crohn's disease, ulcerative colitis, and other digestive conditions.
Vaccines and healthy volunteers. Vaccine studies recruit in Lafayette, and some local studies accept healthy volunteers. If you have never taken part in research, our guide explains how to volunteer for clinical trials.
Other conditions. Studies in heart disease, asthma, COPD, wound care, and weight loss also recruit in the area.
Paid clinical trials in Lafayette and Acadiana
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. Payments are reviewed by the institutional review board that oversees the study, and under FDA guidance they are usually paid out over the course of the study rather than only at the end. Many studies at least cover travel, which helps if you are coming from elsewhere in Acadiana.
Our guide explains how much clinical trials pay and how payment is decided.
Clinical trials in New Iberia, Eunice, and across Acadiana
Some studies recruit at research sites in smaller Acadiana towns such as New Iberia and Eunice, and studies at those sites appear on this page alongside those in Lafayette. For larger hospital programs, see our Baton Rouge page, about an hour east, and our New Orleans page, or browse all Louisiana clinical trials.
How to join a clinical trial in Lafayette
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as Crohn's disease or prostate cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Lafayette or a nearby town such as New Iberia or Eunice.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Can I leave a clinical trial after I join?
Yes. Participation is voluntary, and you can leave a study at any time without affecting your regular medical care. The study team may ask you to come for a final safety visit. Our guide explains informed consent and your rights as a participant.